Immunotherapy – new perspective in lung cancer

doi:10.5306/wjco.v11.i5.250

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9695)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

633

WORD

242

HTML

6016

Figures (1-1)

376

Tables (1-1)

333

Sum=7600

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

851

Download

1244

Sum=2095

May 24, 2020 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. May 24, 2020; 11(5): 250-259
Published online May 24, 2020. doi: 10.5306/wjco.v11.i5.250

Table 1 Ongoing trials on lung cancer immunotherapy

Trial	Aims	Registry number¹
ANVIL	To compare nivolumab vs placebo in stage IB-IIIA squamous NSCLC	NCT02595944
PEARLS	To evaluate pembrolizumab vs placebo in stage IB, II and IIIA NSCLC	NCT02504372
IMpower 010	To randomize stage IB-IIIA NSCLC patients to receive atezolizumab following adjuvant platinum-based chemotherapy or best supportive care	NCT02486718
BR31	To assess durvalumab vs placebo in completely resected tumors	NCT02273375

¹ClinicalTrials.gov registry number. NSCLC: Non-small cell lung cancer.

Citation: Pinheiro FD, Teixeira AF, de Brito BB, da Silva FAF, Santos MLC, de Melo FF. Immunotherapy – new perspective in lung cancer. World J Clin Oncol 2020; 11(5): 250-259
URL: https://www.wjgnet.com/2218-4333/full/v11/i5/250.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i5.250